Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Background & Aim: Aurora kinase A is a member of the serine/threonine kinase family and plays important roles in mitosis
and chromosome stability. This study aimed to evaluate the clinical significance of Aurora kinase A expression in colorectal
cancer patients in Korea.
Methods: Aurora kinase A protein expression was evaluated by immunohistochemistry in 151 patients with colorectal
adenocarcinoma using tissue microarray blocks. We then analyzed the relationship between clinicopathological characteristics
and Aurora kinase A expression. In addition, we assessed the prognostic significance of various clinicopathological data for
progression-free survival.
Results: Aurora kinase A expression was detected in 45% (68/151) of the cases. Positive staining for Aurora kinase A was
observed more often in male patients (P=0.035) and distally located tumors (P=0.021) progression-free survival was shorter in
patients with Aurora kinase A expression compared to those with low-level Aurora kinase A expression (P<0.001). Univariate
analysis revealed that Aurora kinase A expression (P=0.001), age (P=0.034), lymphatic invasion (P=0.001), perineural invasion
(P=0.002), and TNM stage (P=0.013) significantly affected progression-free survival. In a multivariate analysis of progressionfree
survival, a Cox proportional hazard model confirmed that Aurora kinase A expression was an independent and significant
prognostic factor in colorectal adenocarcinoma (hazard ratio, 3.944; P<0.001).
Conclusions: Thus, Aurora kinase A could serve as an independent factor to predict a poor prognosis in Korean colorectal
cancer patients.